Canada markets closed

PsyBio Therapeutics Corp. (PSYBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00740.0000 (0.00%)
At close: 12:47PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 950.16k
Enterprise Value 1.03M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)202.42
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.38

Trading Information

Stock Price History

Beta (5Y Monthly) 0.68
52-Week Change 3-66.29%
S&P500 52-Week Change 322.36%
52 Week High 30.0322
52 Week Low 30.0030
50-Day Moving Average 30.0074
200-Day Moving Average 30.0077

Share Statistics

Avg Vol (3 month) 316k
Avg Vol (10 day) 315.29k
Shares Outstanding 580.85M
Implied Shares Outstanding 6145.09M
Float 879.1M
% Held by Insiders 16.27%
% Held by Institutions 13.57%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 18, 2016
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-209.00%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -2.52M
Net Income Avi to Common (ttm)-1.9M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.37k
Total Cash Per Share (mrq)0
Total Debt (mrq)96.14k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-1.59M
Levered Free Cash Flow (ttm)-343.08k